Share Print

SPOTLIGHTED FUNDING OPPORTUNITY 

University Research Strategic Alliance (URSA)

Call for Research Proposals 2012

The mission of the Office of the Vice Chancellor for Research (OVCR) is to cultivate innovation and research growth, promote the ethical and responsible conduct of research, and serve the Washington University research community. One goal of the OVCR is to foster new interdisciplinary collaborations that result in innovative research. To further this aim, the Vice Chancellor for Research has initiated the second round of the internal funding program called the University Research Strategic Alliance (URSA).

The URSA Program will provide up to six awards, with a value of up to $25,000 each, for seed funding for new interdisciplinary collaborative research projects to full-time faculty at Washington University. URSA is soliciting proposals that include a new collaboration between faculty investigators from different disciplines working together in a new area of research or approaching a problem in an innovative way. The goal is to promote new collaborations that build on different scientific and scholarly backgrounds to facilitate breakthroughs in solving research questions in a collaborative manner, and which will spawn

http://research.wustl.edu/PGC/Funding/Documents/URSA%20RFP%202012%20FINALextended.pdf

Letter of intent due date extended to  Friday, May, 11, 2012.


FOUNDATION OPPORTUNITIES 

Edward Mallinckrodt, Jr. Foundation
Washington University has been invited to submit two proposals for the Edward Mallinckrodt, Jr. Foundation's Grant Program. The Foundation makes grants for the purpose of advancing knowledge in the various fields of medical and health research.
Research Grants ($60,000 per year for up to three years) fund projects that are in need of initial start-up funding to move the projects forward to the point of other independent support or to support highly promising young investigators at a time when start-up funds are limited and initial progress is dependent on additional funding. The foundation particularly encourages applications from physician scientists and candidates within the first few years of appointment to a tenure-track faculty position
http://internalcompetitions.wustl.edu/ocfr/grants.nsf/d20d347a226ec79
c862567ad005a8e33/ca38bc9464fb2f67862575c5005f7fb7?OpenDocument

Deadline for Internal Competition: June 5, 2012

 

NIH & NCI  OPPORTUNITIES

Request for Applications

Program Announcements

 NCI R01 Research on the Health of LGBTI Populations Also R03, and R21
(PA-12-111) This FOA calls for research that describes the biological, clinical, behavioral, and social processes that affect the health and development among LGBTI populations and among their families, and that leads to the development of effective supportive, preventive and treatment interventions and health service delivery methods that will enhance the health and development of these populations.

http://grants.nih.gov/grants/guide/pa-files/PA-12-111.html

http://grants.nih.gov/grants/guide/pa-files/PA-12-112.html

http://grants.nih.gov/grants/guide/pa-files/PA-12-113.html
NIH standard due dates apply.  Next R01 Submission deadline June 5, 2012.

 

NCI K22 The NCI Transition Career Development Award (K22)
(PAR-12-121) This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent.
Application Receipt/Submission Date(s): Multiple dates, see announcement.

NIH standard due dates apply.  Next K22 Submission deadline June 12, 2012

 

NCI R21 Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy 
(PA-12-083)   The purpose of this Funding Opportunity Announcement (FOA) is to encourage basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN).
Letter of Intent due date:  May 16, 2012


NCI R21 Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities
(PAR-12-094)  NCI  invites grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies, development and testing of new methodologies, secondary data analyses, and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities.
Application Receipt/Submission Date(s): June 20, 2012

NCI U01 Basic Cancer Research in Cancer Health Disparities
(PAR-12-095)  This FOA encourage grant applications from investigators interested in conducting basic, mechanistic research into the biologic/genetic causes of cancer health disparities.  This FOA is also designed to aid and facilitate the development of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can develop resources and tools, such as biospecimens, cell lines and methods that are necessary to conduct basic research in cancer health disparities.
Application Receipt/Submission Date(s): June 20, 2012

NCI R21 Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research
(PAR-12-096)   The purpose of this FOA is to improve the diversity of the NCI-funded research workforce by supporting and recruiting eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from socially, culturally, economically, or educationally disadvantaged backgrounds
Application Receipt/Submission Date(s): June 20, 2012

NIH/NCI Cancer Target Discovery and Development (CTDD) Network (U01)  The purpose of this FOA and the Cancer Target Discovery and Development (CTDD) initiative is to promote innovative research on high throughput approaches to the discovery and characterization of new cancer targets and their modulators. Projects resulting from this FOA are expected to bridge the gap between the enormous volumes of data generated by the comprehensive molecular characterizations of many cancer subtypes and the ability to use these data for the development of human cancer therapeutics and associated response markers. Applicants must propose research projects focused on high-throughput identification and/or characterization of potential targets for cancer therapy, and/or the identification of small molecules that modulate validated cancer targets. Proposed projects are expected to combine in-depth mining of large-scale genomic data, systems biology analyses and/or experimental approaches to provide initial characterization of functional significance. This characterization may involve the studies of modulation/perturbation of the potential targets (or target combinations) using, e.g., small molecules and/or oligonucleotides. Development and/or improvement of technologies serving the main goals of the project may also be proposed. In addition to conducting individual research projects, the CTDD awardees will also be expected to contribute to trans-Network activities, including participation in joint pilot research projects. Successful applicants will join the existing Network. Limited competition 2 applications per institution.  LOI (optional) due May 21, 2012;  application due June 21, 2012.

NIH/NCI Translational Research at the Aging/Cancer Interface (TRACI) (R01)  This FOA encourages translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population.  Application deadline:  June 5, 2012

http://grants.nih.gov/grants/guide/pa-files/PA-12-136.html

 

NCI R011 Multidisciplinary Studies of HIV/AIDS and Aging (also R21 and R03))
(PAR-12-175)  The goal of this announcement is to invite research grant applications studying HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings. General topic areas appropriate for this FOA include, but are not limited to the following:
Application Receipt/Submission Date(s): August 7, 2012

 

NCI Administrative SupplementNLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp)
(PA-12-158) These administrative supplements provide funds to supported research and center grants in order to enhance the storage, organization, management and use of electronic research data through the involvement of informationists, also known as in-context information specialists. 

The purposes of this administrative supplement program are (1) to enhance collaborative, multi-disciplinary basic and clinical research by integrating an information specialist into the research team in order to improve the capture, storage, organization, management, integration, presentation and dissemination of biomedical research data and (2) to assess and document the value and impact of the informationist's participation. 

National Library of Medicine
Application Receipt/Submission Date(s): June 5, 2012.



Funding Newsletter Archive